Phadia US INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.6Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
20,745clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $225K
2020 $134K
2021 $198K
2022 $301K
2023 $307K
2024 $290K
2025 $191K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Allergy & Immunology $395K
Clinical Pathology/Laboratory Medicine $221K
Family $139K
Pediatrics $138K
Family Medicine $119K
Allergy & Immunology (Internal Medicine) $115K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Henry Homburger Rochester, MN Clinical Pathology/Laboratory Medicine $220,606.41
Yat Choi Kwong Los Angeles, CA Allergy & Immunology $176,841.88
Sofia Szari Eglin Afb, FL Allergy & Immunology $125,769.74
Geoffrey Carlson Travis Afb, CA Allergy & Immunology (Internal Medicine) $113,018.04
Brett Coons Jb Andrews, MD Allergy $49,274.18
Henry Wojtczak Albuquerque, NM Pediatric Pulmonology $44,734.59
Myron Liebhaber Santa Barbara, CA Allergy & Immunology $38,739.85
Niti Chokshi Houston, TX Pediatric Allergy/Immunology $34,456.79
Saroj Misra Warren, MI Family Medicine $31,950.39
David Schwartz Bethesda, MD Allergy $14,783.31

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.